These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2581331)

  • 21. International collaborative study for the establishment of the second International Reference Preparation of plasmin.
    Gaffney PJ; Mussett MV
    Thromb Haemost; 1983 Oct; 50(3):645-9. PubMed ID: 6228030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A radioimmunoassay for thrombospondin, used in a comparative study of thrombospondin, beta-thromboglobulin and platelet factor 4 in healthy volunteers.
    Dawes J; Clemetson KJ; Gogstad GO; McGregor J; Clezardin P; Prowse CV; Pepper DS
    Thromb Res; 1983 Mar; 29(6):569-81. PubMed ID: 6190242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between low affinity platelet factor 4 (LA-PF4) and beta-thromboglobulin (beta TG).
    Niewiarowski S
    Thromb Haemost; 1980 Aug; 44(1):47. PubMed ID: 6158765
    [No Abstract]   [Full Text] [Related]  

  • 24. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases.
    Arocha-Piñango CL; Ojeda A; López G; García L; Linares J
    Acta Obstet Gynecol Scand; 1985; 64(2):115-20. PubMed ID: 2580418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a proposed international standard for blood coagulation factor IX.
    Brozović M; Kirkwood TB; Robertson I
    Thromb Haemost; 1976 Feb; 35(1):222-36. PubMed ID: 989189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
    Strauss WE; Cella G; Parisi AF; Sasahara AA
    Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
    Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
    Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders?
    Cella G; Scattolo N; Girolami A; Sasahara AA
    Ric Clin Lab; 1984; 14(1):9-18. PubMed ID: 6203164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-released proteins as molecular markers for the activation process.
    Walz DA
    Semin Thromb Hemost; 1984 Oct; 10(4):270-9. PubMed ID: 6240116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma concentrations of plbatelet-specific proteins in coronary artery disease.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaindl F
    Cardiology; 1981; 68(3):129-38. PubMed ID: 6172197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cellulose acetate 0.2 micron filter on platelet specific proteins plasma levels.
    Stevanato F; Paolini R; Fabris F; Casonato A; Cella G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):377-81. PubMed ID: 1703106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
    Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
    J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of anticoagulant mixtures on BTG and PF4 levels.
    Randi ML; Fabris F; Casonato A; Girolami A
    Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
    [No Abstract]   [Full Text] [Related]  

  • 38. Platelet activation indices and apolipoproteins in hypertensive patients.
    Catalano M; Belletti S; Russo U; Aronica A; Carzaniga G; Seregni R; Libretti A
    J Hum Hypertens; 1988 Oct; 2(3):195-7. PubMed ID: 2976836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
    Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
    Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
    Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
    Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.